These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15123870)

  • 1. Toxic epidermal necrolysis treated with intravenous immunoglobulin and granulocyte colony-stimulating factor.
    Kalyoncu M; Cimsit G; Cakir M; Okten A
    Indian Pediatr; 2004 Apr; 41(4):392-5. PubMed ID: 15123870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis.
    Goulden V; Goodfield MJ
    Br J Dermatol; 1996 Aug; 135(2):305-6. PubMed ID: 8881680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor.
    Jarrett P; Rademaker M; Havill J; Pullon H
    Clin Exp Dermatol; 1997 May; 22(3):146-7. PubMed ID: 9425696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxic epidermal necrolysis. Therapy in ICU with intravenous immunoglobulins in a case].
    Andresen M; Boghero Y; Molgó M; Dougnao A; Díaz O
    Rev Med Chil; 2000 Dec; 128(12):1343-8. PubMed ID: 11227243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin in toxic epidermal necrolysis.
    Pasic S
    Int J Dermatol; 2006 Sep; 45(9):1117-8. PubMed ID: 16961531
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
    Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
    Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
    Simeone F; Rubio ER
    J La State Med Soc; 2003; 155(5):266-9. PubMed ID: 14748489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxic epidermal necrolysis treated with intravenous immunoglobulin].
    de Juan Martín F; Bouthelier Moreno M; Marín Bravo MC; Melendo Gimeno J
    An Esp Pediatr; 2002 Apr; 56(4):370-1. PubMed ID: 11927090
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immunoglobulin for the treatment of toxic epidermal necrolysis.
    Trent JT; Kerdel FA
    Arch Dermatol; 2003 Aug; 139(8):1081. PubMed ID: 12925403
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxic epidermal necrolysis 2006.
    Heymann WR
    J Am Acad Dermatol; 2006 Nov; 55(5):867-9. PubMed ID: 17052494
    [No Abstract]   [Full Text] [Related]  

  • 12. IVIG for the treatment of toxic epidermal necrolysis.
    Mittmann N; Chan BC; Knowles S; Shear NH
    Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
    Sidwell RU; Swift S; Yan CL; Porter W; Thompson EM; Clark JA; Bunker CB
    Int J Clin Pract; 2003 Sep; 57(7):643-5. PubMed ID: 14529073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic epidermal necrolysis in systemic lupus erythematosus.
    Horne NS; Narayan AR; Young RM; Frieri M
    Autoimmun Rev; 2006 Feb; 5(2):160-4. PubMed ID: 16431352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic epidermal necrolysis secondary to angioimmunoblastic T-cell lymphoma.
    Jones B; Vun Y; Sabah M; Egan CA
    Australas J Dermatol; 2005 Aug; 46(3):187-91. PubMed ID: 16008654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic epidermal necrolysis and intravenous immunoglobulin: a review.
    Trent J; Halem M; French LE; Kerdel F
    Semin Cutan Med Surg; 2006 Jun; 25(2):91-3. PubMed ID: 16908399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetaminophen-induced toxic epidermal necrolysis in a child.
    Bygum A; Gregersen JW; Buus SK
    Pediatr Dermatol; 2004; 21(3):236-8. PubMed ID: 15165202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic epidermal necrolysis successfully treated with etanercept.
    Gubinelli E; Canzona F; Tonanzi T; Raskovic D; Didona B
    J Dermatol; 2009 Mar; 36(3):150-3. PubMed ID: 19335689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of toxic epidermal necrolysis/Stevens-Johnson syndrome overlap with human granulocyte colony stimulating factor: a case report.
    Pallesen KA; Robinson S; Toft P; Andersen KE
    Acta Derm Venereol; 2012 Mar; 92(2):212-3. PubMed ID: 22068367
    [No Abstract]   [Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN management protocol [corrected].
    de Sica-Chapman A; Williams G; Soni N; Bunker CB
    Br J Dermatol; 2010 Apr; 162(4):860-5. PubMed ID: 19912214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.